PacBio Announces Plans to Improve Methylation Detection in HiFi Chemistry
GlobeNewswire· 2025-04-28 21:05
文章核心观点 公司计划通过授权香港中文大学开发的先进DNA甲基化检测方法,提升HiFi化学中已有的高精度甲基化检测能力,为客户提供更全面的表观基因组见解,推动基因组研究和临床应用 [1] 公司合作与技术授权 - 公司宣布计划通过授权香港中文大学Dennis Lo教授及其同事开发的先进DNA甲基化检测方法,提升HiFi化学中高精度甲基化检测能力 [1] - 授权技术包括增强的AI深度学习框架HK2,可显著提高5mC和6mA检测准确性,并首次在单分子中引入天然5hmC检测 [2] 技术优势与应用 - HiFi测序可从天然DNA中全面同时读取基因组和表观基因组,无需化学转化、额外样本制备或并行工作流程 [3] - HK2模型的新功能将通过软件更新提供给现有客户,无需更改测序协议和额外成本 [3] - 准确检测天然分子上的DNA甲基化对癌症、人类发育等研究很重要,HK2改进的PacBio HiFi测序有望为行业准确性设定新标准 [4] - 5hmC分析为液体活检、癌症检测和无细胞DNA分析开辟新领域,公司的天然检测方法可保持DNA完整性并支持复杂基因组区域的单倍型解析分析 [6] 过往成果与未来目标 - 香港中文大学与Take2 Technologies Limited于2021年在PacBio平台上率先实现可靠的5mC检测,公司于2022年4月推出仪器上5mC检测,并于2024年12月将支持扩展到6mA [4] - 公司旨在通过未来软件更新将新功能提供给Revio和Vega系统 [8] 公司与合作方介绍 - 公司是一家生命科学技术公司,设计、开发和制造先进测序解决方案,产品基于HiFi长读长测序和SBB短读长测序技术 [9] - 香港中文大学是一所领先的综合研究型大学,在分子诊断研究方面处于领先地位,其附属的Centre for Novostics致力于分子诊断研究 [11] - Take2是一家香港生物技术公司,专注于新型分子诊断方法的开发,特别是表观遗传分析和癌症筛查领域 [12]
Getty Images and Ancestry Partner to Digitally Preserve Historic Archives of HBCUs
GlobeNewswire· 2025-04-28 20:58
文章核心观点 Getty Images与Ancestry达成专注于族谱的合作,通过HBCU Grants Program对HBCUs历史文献和照片档案进行数字化保存,让人们能在Ancestry网站搜索相关内容,以保护HBCUs宝贵历史并促进全球受众了解其故事 [5] 合作双方 - Getty Images是全球领先的视觉内容创作者和市场平台 [5] - Ancestry是全球家族历史领域的领导者 [5] 合作内容 - 作为Getty Images的HBCU Grants Program一部分,专注于HBCUs历史文献、记录和照片档案的数字化保存与可访问性 [5] - Ancestry与参与的HBCUs合作,识别并数字化如时事通讯、报纸、公告、学生记录等文件和照片 [6] - 合作确保HBCUs除图像外的重要资源得到保护,正确应用元数据 [6] 合作意义 - Getty Images全球合作伙伴副总裁兼HBCU Grants Program执行董事表示,合作增强保护HBCUs宝贵历史的承诺,增加全球受众对其故事的访问、可见性和认识,通过族谱连接各方,为历史研究创造更丰富背景 [7] - Ancestry美国内容和慈善倡议负责人称,结合历史机构档案与Ancestry技术,保护重要文件,让家庭揭开HBCU校友和祖先的故事 [8] 合作案例 - 合作始于美国宾夕法尼亚州的林肯大学,该校去年加入HBCU Grants Program,其数百张当代和档案照片可在gettyimages.com上授权使用 [8] - Ancestry已开始数字化林肯大学的历史文献和数百张照片 [8] - 林肯大学校长表示,合作结合Getty Images和Ancestry的优势,丰富教育项目,促进与遗产的联系,让社区探索和庆祝学校丰富历史 [11] 相关信息获取 - 可点击链接获取公告相关媒体片段 [4][12] - 可访问https://www.gettyimages.com/corporate - responsibility/hbcu - partnership了解HBCU Grants Program更多信息 [11]
Park Street A/S announces results of annual general meeting 2025
GlobeNewswire· 2025-04-28 20:55
文章核心观点 Park Street A/S召开2025年年度股东大会并通过多项决议 [1][2] 股东大会相关情况 - 2025年按2025年4月4日公布的通知和议程召开年度股东大会 [1] - 股东大会后董事会组建,Claes Peter Rading任董事会主席 [2] 股东大会通过的决议 - 批准2024财年经审计的年度报告 [2] - 批准将2024财年按已批准年度报告的结果结转至2025财年 [2] - 批准2024财年薪酬报告 [2] - 决议通过注销库存股减少名义金额为13794324丹麦克朗的股本 [2] - 重新选举Anita Nassar、Pradeep Pattem、Ohene Aku Kwapong、Claes Peter Rading和Medha Pattem为董事会成员,选举Dhruv Pattem为董事会成员 [2] - 重新选举普华永道丹麦授权审计合伙企业为公司审计师 [2] - 授权股东大会主席(有委托权)向丹麦商业管理局提交通过的决议 [2]
FEMSA Announces First Quarter 2025 Results
GlobeNewswire· 2025-04-28 20:50
MONTERREY, Mexico, April 28, 2025 (GLOBE NEWSWIRE) -- Fomento Económico Mexicano, S.A.B. de C.V. (“FEMSA”) (NYSE: FMX; BMV: FEMSAUBD, FEMSAUB) announced today its operational and financial results for the first quarter of 2025. FEMSA: Total Consolidated Revenues grew 11.1% and Income from Operations increased 4.9% compared to 1Q24.FEMSA Retail1: Proximity Americas total Revenues grew 6.8% and Income from operations decreased 11.8% versus 1Q24.SPIN: Spin by OXXO had 8.9 million active users2 representing 20. ...
Artelo Biosciences Announces Publication of New Peer-Reviewed Research Demonstrating ART26.12's Effectiveness in Treating Psoriasis
GlobeNewswire News Room· 2025-04-28 20:45
SOLANA BEACH, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatological or neurological conditions, today announced new research published in the peer-reviewed Journal of Investigative Dermatology describing the positive effects of ART26.12 in both in vitro and in vivo psoriasis models, showing results comparable to immunom ...
SELLAS Unveils Breakthrough Preclinical Data Highlighting Efficacy of SLS009 in TP53 Mutated AML at the 2025 AACR Conference
GlobeNewswire· 2025-04-28 20:45
New Data Suggest SLS009 (tambiciclib) May Overcome Resistance to Azacitidine-Venetoclax Regimen and Trigger Apoptosis of TP53 Mutated AML CellsNEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that preclinical efficacy of SLS009 in TP53 mutated Acute Myeloid Leukemia (AML) cells are being ...
Block Advisors by H&R Block Now Accepting Entries for Second Annual ‘Fund Her Future’ Grant Program Created to Help Female Founders Thrive, Fuel Small Business Growth
GlobeNewswire· 2025-04-28 20:45
The Block Advisors program will grant $100,000 total and a year of small business services to six women-owned businesses dedicated to improving their communitiesKANSAS CITY, Mo., April 28, 2025 (GLOBE NEWSWIRE) -- Block Advisors by H&R Block today announced the return of its Fund Her Future grant program. Starting today, applications are being accepted through May 30, 2025. In its second year, the 2025 program is recognizing six women-owned small businesses with high growth and community impact potential. G ...
Cannabix Enters Sales Distribution Agreement with Alco Prevention Canada for BreathLogix Autonomous Alcohol Breathalyzer
GlobeNewswire· 2025-04-28 20:45
Cannabix has developed an autonomous alcohol breathalyzer screening device for employers and a range of industries and safety settingsVANCOUVER, British Columbia, April 28, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana and alcohol breath devices is pleased to report that it has entered into a non-exclusive distribution agreement (“Agreement”) with Alco Prevention Canada (“Alco Prevention”) for North Americ ...
ReShape Lifesciences® Receives Notice of Allowance for Key U.S. Patent Related to an Intragastric Balloon System
GlobeNewswire· 2025-04-28 20:31
Patent Expands and Strengthens Intellectual Property Portfolio Around a Swallowable and Degradable Intragastric DeviceIRVINE, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that the company has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for patent application 18/241,151, entitled, “Intragastric Device.” When issued, the patent will cover claims ...
New MetaMask Metal Payment Card: Self-Custody Crypto Card With Direct Payments Unveiled by CompoSecure, Baanx and MetaMask
GlobeNewswire· 2025-04-28 20:30
A simple, secure, and direct way to spend crypto directly from MetaMask, one of the world’s leading self-custody wallet providers The MetaMask metal payment card CompoSecure, Inc., a leader in metal payment cards, security, and authentication solutions, in collaboration with Baanx and MetaMask, today announced the launch of the MetaMask metal payment card. SOMERSET, N.J., April 28, 2025 (GLOBE NEWSWIRE) -- CompoSecure, Inc. (“CompoSecure”) (NASDAQ: CMPO), a leader in metal payment cards, security, and a ...